Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Apr 15 1999
WASHINGTON, D.C. (April 15, 1999) Genomics is revolutionizing biology and biotechnology research, greatly accelerating the discovery of new therapies...
Apr 8 1999
WASHINGTON, D.C.(April 8, 1999) Heart disease claims 10 times as many lives as breast cancer and 42 percent of women die within a year of a heart attack...
Apr 8 1999
WASHINGTON, D.C.(April 8, 1999) BIO's board of directors approved a statement opposing discriminatory misuse of medical information, including all...
Mar 31 1999
  WASHINGTON, D.C., (March 31, 1999) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on...
Mar 31 1999
March 31, 1999 (Washington, D.C.) - Environmentally sustainable agriculture and great tasting, more healthful foods are the focus of "Agriculture...
Mar 29 1999
BIO's board of directors has approved a Medicare Modernization Position, which gives BIO a clear standard with which to evaluate all Medicare...
Mar 16 1999
Washington, D.C. (March 16, 1999) The Biotechnology Industry Organization (BIO) today honored Massachusetts Rep. Lida E. Harkins (D-Needham) as BIO State...
Mar 16 1999
  Washington, DC(March 16, 1999) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in...
Mar 15 1999
March 15, 1999 (Washington, D.C.) - The first-ever analysis of biotechnology's impact on crop protection and benefits to the environment finds...


Biotechnology News

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30...

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative...